Newton, MA, United States of America

Ellen R Laird


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ellen R Laird

Introduction

Ellen R Laird is a notable inventor based in Newton, MA (US). She has made significant contributions to the field of biochemistry, particularly in the study of protein kinases. Her work has implications for the development of pharmaceutical compositions aimed at inhibiting specific biological functions.

Latest Patents

Ellen R Laird holds a patent for her invention titled "Three dimensional structure of a ZAP tyrosine protein kinase fragment and modeling methods." This invention focuses on the human ZAP-70 protein, specifically the tandem Src homology-2 (SH2) domains. The patent describes crystalline forms of the protein, both liganded and unliganded, which are essential for determining the three-dimensional structure of ZAP-70. This structural information is crucial for designing pharmaceutical compositions that can inhibit the biological functions of ZAP and related proteins.

Career Highlights

Ellen R Laird is associated with Ariad Pharmaceuticals, Inc., where she applies her expertise in protein structure and function. Her work at the company has contributed to advancements in targeted therapies for various diseases.

Collaborations

Ellen has collaborated with notable colleagues, including Marcos H Hatada and Xiaode Lu. These collaborations have further enriched her research and development efforts in the field of biochemistry.

Conclusion

Ellen R Laird's innovative work in the field of protein kinases and her patent on the ZAP-70 protein structure highlight her contributions to biochemistry and pharmaceutical development. Her research continues to pave the way for new therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…